Latest posts by Lancet Global Health (see all)
- [Comment] Recognising the role of community-directed treatment and of women in the fight… - Apr. 20, 2017
- [Articles] Progress and inequities in maternal mortality in Afghanistan (RAMOS-II): a… - Apr. 15, 2017
- [Articles] Pathways between childhood trauma, intimate partner violence, and harsh parenting:… - Apr. 14, 2017
- [Articles] Complementary feeding at 4 versus 6 months of age for preterm infants born at less… - Apr. 14, 2017
David Osrin and Tim Colbourn (November, 2016)1 uphold a recommendation to restrict use of chlorhexidine to “infants born at home in environments with high neonatal mortality rates” and assert that “Cochrane reviews, a meta-analysis, and these two new trials have not supported an effect after hospital births”. We do not think it is clear how one could come to such a conclusion from the evidence in the cited papers.
Read article here: